Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2007

Aug 4, 2007

30786_dirs_2007-08-03_fe7a7765-ca3d-4b53-a567-9ef6dac2a91e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (bio,bio.b)
CIK: 0000012208
Period of Report: 2007-03-13

Reporting Person: SCHWARTZ DAVID (Director, Chairman of the Board, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-03-13 Bio-Rad A Common Stock G 350 Disposed 2033422 Direct
2007-03-13 Bio-Rad B Common Stock G 2100 Disposed 259676 Direct
2007-08-01 Bio-Rad B Common Stock A 1670 Acquired 261346 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-08-01 Non-Qualified Stock Option (right to buy) $75 A 5000 Acquired 2017-08-01 Bio-Rad B Common Stock (5000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 34311 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 41176 Indirect
Bio-Rad A Common Stock 1140000 Indirect

Footnotes

F1: The shares are held by a limited partnership of which the reporting person is a general partner.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner.

F3: These shares were previously reported as directly beneficially owned but were contributed to a grantor retained annuity trust on 3/15/2007.